Bionano Genomics, Inc. (BMV:BNGO)
31.00
-2.21 (-6.65%)
At close: Dec 3, 2025
Bionano Genomics Revenue
Bionano Genomics had revenue of $7.37M USD in the quarter ending September 30, 2025, with 21.31% growth. This brings the company's revenue in the last twelve months to $28.72M, down -13.84% year-over-year. In the year 2024, Bionano Genomics had annual revenue of $30.78M, down -14.79%.
Revenue (ttm)
$28.72M
Revenue Growth
-13.84%
P/S Ratio
0.59
Revenue / Employee
$287.20K
Employees
100
Market Cap
311.04M MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.78M | -5.34M | -14.79% |
| Dec 31, 2023 | 36.12M | 8.31M | 29.90% |
| Dec 31, 2022 | 27.80M | 9.82M | 54.62% |
| Dec 31, 2021 | 17.98M | 9.48M | 111.47% |
| Dec 31, 2020 | 8.50M | -1.63M | -16.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 1.00T |
| Arca Continental | 250.90B |
| Industrias Peñoles | 142.01B |
| Grupo Financiero Banorte | 134.72B |
| Grupo Elektra | 114.48B |
| Quálitas Controladora | 72.66B |
| GMéxico Transportes | 64.06B |
| Becle | 44.91B |